HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protoporphyrin IX formation after application of methyl aminolevulinate on the face and scalp with and without prior curettage.

AbstractBACKGROUND:
Pulse photodynamic therapy (PDT) is carried out as classical PDT except that methyl aminolaevulinate (MAL) is removed after 30 min. Protoporphyrin IX (PpIX) accumulation becomes lower after 3 h in pulse-PDT than in classical PDT, but pulse-PDT still has full treatment effect on actinic keratosis (AK). The present study aimed to investigate when PpIX formation in classical PDT without curettage reaches the PpIX level in pulse-PDT with curettage in the skin of the face and scalp.
METHODS:
Fourteen patients with AKs in the face and scalp were included in this pilot study. Each patient had two fields randomly allocated to two different regimes: (i) continuing MAL incubation without prior curettage (-Cur) and (ii) 30 min MAL incubation after curettage (+Cur). The PpIX level in each field was measured with a hand-held fluorescence photometer every 30 min for 6 h after MAL application. No illumination was performed.
RESULTS:
The median PpIX level in the +Cur field after 3 h was 22 arbitrary units (AU), which represents the amount of PpIX that could have been photobleached after pulse-PDT with maximal treatment effect. After 3 h the median PpIX level in the -Cur field was 20 AU, which was not significantly different from the level in the +Cur field (p = 0.9).
CONCLUSIONS:
We propose PDT without curettage as follows: 3 h of MAL incubation and subsequently sufficient illumination. The treatment effect of this regime should be tested to verify if curettage of the face and scalp area may be omitted in PDT.
AuthorsIda M Heerfordt, Giedre Bieliauskiene, Hans Christian Wulf
JournalPhotodiagnosis and photodynamic therapy (Photodiagnosis Photodyn Ther) Vol. 22 Pg. 155-157 (Jun 2018) ISSN: 1873-1597 [Electronic] Netherlands
PMID29601904 (Publication Type: Journal Article, Randomized Controlled Trial)
CopyrightCopyright © 2018 Elsevier B.V. All rights reserved.
Chemical References
  • Photosensitizing Agents
  • Protoporphyrins
  • methyl 5-aminolevulinate
  • Aminolevulinic Acid
  • protoporphyrin IX
Topics
  • Aged
  • Aged, 80 and over
  • Aminolevulinic Acid (administration & dosage, analogs & derivatives, pharmacokinetics, therapeutic use)
  • Curettage
  • Face
  • Female
  • Humans
  • Keratosis, Actinic (drug therapy)
  • Male
  • Middle Aged
  • Photochemotherapy (methods)
  • Photosensitizing Agents (administration & dosage, pharmacokinetics, therapeutic use)
  • Pilot Projects
  • Protoporphyrins (pharmacokinetics)
  • Scalp

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: